Riskpilot← Back to searchSign inGet full accessSLANK ApS
APSActiveCVR 31895626Græshave Alle 26Other financial service activities, except insurance and pension funding n.e.c. · NACE 6499Est. 2008— employees
Revenue 2025
DKK -375K
-1535% vs 2024
EBITDA margin
100.0%
-1535% vs 2024
Equity ratio
83.8%
Financial strength
Net profit 2025
DKK -11M
-246% vs 2024
| Revenue | DKK -375K | -1535% |
| EBITDA | DKK -375K | -1535% |
| Net profit | DKK -11M | -246% |
| Total assets | DKK 12,6M | -50% |
| Equity | DKK 10,6M | -52% |
| Employees | — | — |
Legal name
SLANK ApS
CVR number
31895626
Legal form
Anpartsselskab
NACE code
6499 · Other financial service activities, except insurance and pension funding n.e.c.
Founded
18. december 2008
Share capital
DKK 125.000
Employees
—
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er at drive virksomhed med videreudvikling og salg af bioteknologi. Som bibranche udlejning og leasing af biler og lette køretøjer og pengeudlån. Samt efter direktionens skøn beslægtet virksomhed, herunder som holdingselskab.
Address
Græshave Alle 26
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 75 | -438 | -447 | 26 | -375 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 75 | -438 | -447 | 26 | -375 |
| Depreciation & amort. | -172 | -60 | -71 | -109 | -145 |
| EBIT | -97 | -497 | -518 | -83 | -520 |
| Net financials | 2.282 | 1.814 | 4.793 | 9.706 | -10.466 |
| Profit before tax | 2.184 | 1.317 | 4.275 | 9.623 | -10.986 |
| Tax | 463 | 294 | 943 | 2.103 | -0 |
| Net profit | 1.722 | 1.022 | 3.332 | 7.521 | -10.986 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 13.505 | 14.563 | 16.404 | 25.122 | 12.599 |
| Equity | 12.859 | 13.782 | 15.214 | 21.869 | 10.553 |
| Long-term debt | 0 | 285 | 897 | 2.030 | 0 |
| Short-term debt | 645 | 496 | 293 | 1.223 | 2.046 |
| Total debt | 645 | 782 | 1.191 | 3.252 | 2.046 |
EBITDA margin
-37542300.0%
This company
15.8%
Market median
-237609594% vs market
20212025
Equity ratio
83.8%
This company
38.2%
Market median
+119% vs market
20212025
Return on equity
-104.1%
This company
18.4%
Market median
-666% vs market
20212025
Net profit margin
-1098643500.0%
This company
8.1%
Market median
-13563500100% vs market
20212025
Asset turnover
-0.03×
This company
1.12×
Market median
-103% vs market
20212025
Debt / equity
0.19×
This company
0.62×
Market median
+69% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
No data on file.
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 25–33.32% | 5–9.99% | 2008 | |
| Individual | 25–33.32% | 5–9.99% | 2008 | |
| Individual | 25–33.32% | 5–9.99% | 2008 | |
| Individual | 10–14.99% | 33.33–49.99% | 2008 | |
| Individual | 10–14.99% | 33.33–49.99% | 2008 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
SLANK ApS 
V-BIOTEK HOLDING ApSBoard members of SLANK ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|